- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 449
Motiv Power pulls in $15m
GMAg provided $15m in convertible note financing that will be put towards the Winnebago-backed electrification equipment maker's ongoing series C round.
Aug 27, 2020SparkMeter measures $12m in series A funding
Total Energy Ventures helped the utility-scale energy meter provider close a round that will support the launch of its latest software product.
Aug 27, 2020Cisco signs up for BabbleLabs acquisition
Dell Technologies Capital and Intel Capital are set to exit the audio enhancement technology provider, which has agreed to be bought by Cisco.
Aug 26, 2020Daily deal net: August 26, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Aug 26, 2020Palantir reveals filing for direct listing
The Sompo, Fujitsu and Relx-backed data miner, which has raised some $2.7bn in venture funding, has chosen the New York Stock Exchange to list its shares.
Aug 26, 2020Bionano Genomics takes up Lineagen
University of Utah autism diagnosis service provider Lineagen has been snapped up in a transaction worth at least $9.6m in cash, stocks and liabilities.
Aug 26, 2020Lyra Health rings in $110m series D
Mental health benefits provider Lyra Health once again secured funding from Providence Ventures, as part of a round that pushed its valuation to $1.1bn.
Aug 26, 2020Mural raises $118m more
Corporate venturing units Slack Fund and Gradient Ventures contributed to a series B round that increased the online whiteboard developer's total funding to about $143m.
Aug 26, 2020Yumanity and Proteostasis pursue reverse merger
Yumanity Therapeutics will take over Nasdaq-listed Proteostasis in a reverse merger after raising more than $100m from investors including Biogen, Merck & Co, Pfizer and Sanofi.
Aug 26, 2020Acadia absorbs Cersci for $52.5m
UT Dallas spinout Cersci Therapeutics has been acquired in a deal potentially worth nearly $940m, including a $52.5m upfront payment.
Aug 26, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


